Sign in

CIK 0001287098 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

MAXCYTE, INC.

Sign in to watch
Ticker
MXCT
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
522210438
Phone
301-517-5556
Business address
9713 KEY WEST AVENUE,, SUITE 400, ROCKVILLE, MD, 20850
Former names
MAXCYTE INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 42 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-27 Johnston John Joseph Director Sale 10b5-1 −7,471 $4.39 $33K 120,583
2023-06-27 Johnston John Joseph Director Option exercise · Stock Option (right to buy) 10b5-1 −7,471 18,717
2023-06-26 Johnston John Joseph Director Option exercise 10b5-1 +6,817 $0.98 $7K 127,400
2023-06-26 Johnston John Joseph Director Option exercise 10b5-1 +712 $1.64 $1K 128,112
2023-06-26 Johnston John Joseph Director Sale 10b5-1 −7,529 $4.49 $34K 120,583
2023-06-26 Johnston John Joseph Director Option exercise · Stock Option (right to buy) 10b5-1 −6,817 0
2023-06-26 Johnston John Joseph Director Option exercise · Stock Option (right to buy) 10b5-1 −712 26,188
2023-06-22 Al-Wakeel Yasir B. Director Grant or award · Stock Option (right to buy) +50,000 50,000
2023-06-22 Brooke William W Director Grant or award · Stock Option (right to buy) +50,000 50,000
2023-06-22 Erck Stanley C Director Grant or award · Stock Option (right to buy) +50,000 50,000
2023-06-22 DOUGLAS RICHARD Director Grant or award · Stock Option (right to buy) +50,000 50,000
2023-06-22 Hemrajani Rekha Director Grant or award · Stock Option (right to buy) +50,000 50,000
2023-06-22 BALTHROP PATRICK J Director Grant or award · Stock Option (right to buy) +50,000 50,000
2023-06-22 Johnston John Joseph Director Grant or award · Stock Option (right to buy) +50,000 50,000
2023-06-22 Mandell Art Director Grant or award · Stock Option (right to buy) +50,000 50,000
2023-06-14 Doerfler Douglas President and CEO Option exercise 10b5-1 +28,883 $0.04 $1K 362,080
2023-06-14 Doerfler Douglas President and CEO Sale 10b5-1 −28,883 $5.04 $146K 333,197
2023-06-14 Doerfler Douglas President and CEO Option exercise · Employee Stock Option (right to buy) 10b5-1 −28,883 265,080
2023-06-13 Doerfler Douglas President and CEO Option exercise 10b5-1 +14,968 $0.04 $599 348,165
2023-06-13 Doerfler Douglas President and CEO Sale 10b5-1 −14,968 $5.03 $75K 333,197

Page 11 of 15 · 282 trades